While at the 2015 ECC conference in Vienna, Austria, Dr. Makoto Tahara spoke with us about what he thought were the best presentations and posters from the conference, and what was emerging in induction therapy and maintenance in head and neck cancer. We also discussed what is on the horizon for biomarkers and treating HPV and non-HPV related cancers of the head and neck.
advertisement
Interview with Makoto Tahara, MD, PhD | Japan
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Overview
Publication Dates
Release Date:
Recommended
Details
Overview
While at the 2015 ECC conference in Vienna, Austria, Dr. Makoto Tahara spoke with us about what he thought were the best presentations and posters from the conference, and what was emerging in induction therapy and maintenance in head and neck cancer. We also discussed what is on the horizon for biomarkers and treating HPV and non-HPV related cancers of the head and neck.
Publication Dates
Release Date:
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
advertisement
Recommended
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?